Antibiotic Expenditures by Medication, Class, and Healthcare Setting in the United States, 2010-2015

Clinical Infectious Diseases

Volumn 66, Issue 2, 2018, Pages 185-190

  Suda, Katie J ^a,b   Hicks, Lauri A ^c   Roberts, Rebecca M ^c   Hunkler, Robert J ^d   Matusiak, Linda M ^d   Schumock, Glen T ^b  

^a HINES VA HOSPITAL   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d IQVIA   (United States)

Author keywords

antibiotic; community; expenditures; outpatient parenteral antimicrobial therapy; stewardship

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIMICROBIAL STEWARDSHIP; ANTIMICROBIAL THERAPY; COMMUNITY; CONFERENCE PAPER; DRUG COST; DRUG FORMULATION; HEALTH CARE COST; HEALTH CARE FACILITY; HUMAN; OUTPATIENT CARE; PHARMACY; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREND STUDY; UNITED STATES; DRUG UTILIZATION; ECONOMICS; PROCEDURES;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL STEWARDSHIP; DRUG UTILIZATION; HEALTH EXPENDITURES; HUMANS; UNITED STATES;

EID: 85040540290     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix773     Document Type: Conference Paper

References (40)

1. Davey P, Brown E, Charani E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2013; 4:CD003543.
2. Filice G, Drekonja D, Greer N, et al. Antimicrobial stewardship programs in inpatient settings: A systematic review. VA-ESP Project #09-009. Washington, DC: Department of Veterans Affairs, 2013.
3. Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of inappropriate antibiotic prescriptions among U.S. ambulatory care visits, 2010-2011. JAMA 2016; 315:1864-73.
4. Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 2003; 163:972-8.
5. Fridkin S, Baggs J, Fagan R, et al.; Centers for Disease Control and Prevention (CDC). Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep 2014; 63:194-200.
6. Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-Associated adverse events. Clin Infect Dis 2008; 47:735-43.
7. Jacob JT, Gaynes RP. Emerging trends in antibiotic use in US hospitals: quality, quantification and stewardship. Expert Rev Anti Infect Ther 2010; 8:893-902.
8. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-Analysis. BMJ 2010; 340:c2096.
9. Spellberg B, Guidos R, Gilbert D, et al.; Infectious Diseases Society of America. The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008; 46:155-64.
10. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Available at: https://www.cdc.gov/drugresistance/threat-report-2013/. Accessed 1 June 2017.
11. Doron S, Nadkarni L, Lyn Price L, et al. A nationwide survey of antimicrobial stewardship practices. Clin Ther 2013; 35:758-65.e20.
12. Dellit TH, Owens RC, McGowan JE Jr, et al; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44:159-77.
13. Pollack LA, Srinivasan A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis 2014; 59(suppl 3):S97-100.
14. Presidents Council of Advisors on Science and Technology. Report to the President on combating antibiotic resistance. The White House website. 2015. Available at: https://www.whitehouse.gov/sites/default/files/microsites/ostp/PCAST/pcast-Amr-jan2015.pdf. Accessed 1 June 2017.
15. Schumock GT, Li EC, Suda KJ, et al. National trends in prescription drug expenditures and projections for 2015. Am J Health Syst Pharm 2015; 72:717-36.
16. Cuckler GA, Sisko AM, Keehan SP, et al. National health expenditure projections, 2012-22: slow growth until coverage expands and economy improves. Health Aff (Millwood) 2013; 32:1820-31.
17. Hoffman JM, Doloresco F, Vermeulen LC, et al. Projecting future drug expenditures-2010. Am J Health Syst Pharm 2010; 67:919-28.
18. Schumock GT, Li EC, Suda KJ, et al. National trends in prescription drug expenditures and projections for 2014. Am J Health Syst Pharm 2014; 71:482-99.
19. Hoffman JM, Li E, Doloresco F, et al. Projecting future drug expenditures in U.S. nonfederal hospitals and clinics-2013. Am J Health Syst Pharm 2013; 70:525-39.
20. Hoffman JM, Li E, Doloresco F, et al. Projecting future drug expenditures-2012. Am J Health Syst Pharm 2012; 69:405-21.
21. Doloresco F, Fominaya C, Schumock GT, et al. Projecting future drug expenditures: 2011. Am J Health Syst Pharm 2011; 68:921-32.
22. Schumock GT, Li EC, Suda KJ, et al. National trends in prescription drug expenditures and projections for 2016. Am J Health Syst Pharm 2016; 73:1058-75.
23. Suda KJ, Hicks LA, Roberts RM, Hunkler RJ, Danziger LH. A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009. J Antimicrob Chemother 2013; 68:715-8.
24. Boardman C; IMS Health Incorporated. System and method for estimating product distribution using a product specific universe. US Patent No. 7, 174, 304. 2007.
25. Centers for Disease Control and Prevention Health Advisory. Nationwide shortage of doxycycline: resources for providers and recommendations for patient care. 2013. Available at: https://emergency.cdc.gov/han/han00349.asp. Accessed 1 June 2017.
26. Quadri F, Mazer-Amirshahi M, Fox ER, et al. Antibacterial drug shortages from 2001 to 2013: implications for clinical practice. Clin Infect Dis 2015; 60:1737-42.
27. Langreth R. Rigging charge exposes one reason for inexplicable drug pricing. Bloomberg. 2016. Available at: https://www.bloomberg.com/news/articles/2016-12-16/rigging-charge-exposes-fish-Tale-behind-high-Antibiotic-prices. Accessed 1 June 2017.
28. Schoenberg T, McLaughlin D, Pearson S. U.S. generic drug probe seen expanding after guilty pleas. Bloomberg 2016. Available at: https://www.bloomberg.com/news/articles/2016-12-14/u-s-files-first-charges-in-generic-drug-price-fixingprobe. Accessed 9 September 2017.
29. Medscape. FDA approves first generic versions of levofloxacin. 2011. Available at: http://www.medscape.com/viewarticle/745007. Accessed 1 June 2017.
30. Suda KJ, Hicks LA, Roberts RM, Hunkler RJ, Taylor TH. Trends and seasonal variation in outpatient antibiotic prescription rates in the United States, 2005 to 2010. Antimicrob Agents Chemother 2014; 58:2763-6.
31. Hicks LA, Bartoces MG, Roberts RM, et al. US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. Clin Infect Dis 2015; 60:1308-16.
32. Gordon SM, Shrestha NK, Rehm SJ. Transitioning antimicrobial stewardship beyond the hospital: The Cleveland Clinics community-based parenteral anti-infective therapy (CoPAT) program. J Hosp Med 2011; 6(suppl 1):S24-30.
33. Goldman JL, Richardson T, Newland JG, et al. Outpatient parenteral antimicrobial therapy in pediatric Medicaid enrollees. J Pediatric Infect Dis Soc 2017; 6:65-71.
34. Spivak ES, Kendall B, Orlando P, et al. Evaluation of outpatient parenteral antimicrobial therapy at a Veterans Affairs hospital. Infect Control Hosp Epidemiol 2015; 36:1103-5.
35. Davey P, Parker S. Cost effectiveness of once-daily oral antimicrobial therapy. J Clin Pharmacol 1992; 32:706-10.
36. European Centre for Disease Prevention and Control. Annual epidemiological report 2014. Antimicrobial resistance and healthcare-Associated infections. Stockholm: ECDC, 2014.
37. Swedish Veterinary Antimicrobial Resistance Monitoring. Swedres-Svarm report summary 2014. Available at: http://www.sva.se/en/antibiotics-/svarm-reports. Accessed 1 June 2017.
38. Centers for Disease Control and Prevention. Outpatient antibiotic prescriptions-United States, 2014. Available at: https://www.cdc.gov/getsmart/community/pdfs/annual-reportsummary-2014.pdf. Accessed 1 June 2017.
39. Sanchez GV, Fleming-Dutra KE, Roberts RM, Hicks LA. Core elements of outpatient antibiotic stewardship. MMWR Recomm Rep 2016; 65:1-12.
40. Centers for Disease Control and Prevention. Get smart: know when antibiotics work. Available at: https://www.cdc.gov/getsmart/community/programs-measurement/national-Activities/antibiotics-work.html. Accessed 23 July 2017.